On 19 November 2012, Amsterdam Molecular Therapeutics (AMT) Holding N.V. delisted from NYSE Euronext in  Amsterdam  and the company and its shares ceased to exist.

For more information please click here

Latest News

Listing Amsterdam Molecular Therapeutics terminates and company and its shares cease to exist
Nov 16, 2012 > Read More
Amsterdam Molecular Therapeutics (in liquidation) announces delisting and expected finalisation of liquidation process
Nov 6, 2012 > Read More
From Care to Cure